UPDATED May 18, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AFT | R68.55 | 4.3% | 31.1% | R10.4b | R86.00 | PE13.2x | E38.1% | 2.2% | Materials | ||
MIX | R11.00 | 0% | 90.3% | R6.1b | n/a | PE58.7x | E46.2% | 1.6% | Software | ||
APN | R229.79 | -0.09% | 37.0% | R102.2b | R238.21 | PE21x | E27.2% | 1.5% | Pharmaceuticals & Biotech | ||
CPI | R2,270.00 | -1.1% | 55.2% | R262.9b | R2,260.45 | PB6x | E16.7% | 2.1% | Banks | ||
DTC | R37.78 | -3.7% | 4.8% | R8.6b | R59.38 | PB1x | E71.1% | 4.8% | Tech |